Menu Close
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
    • Literature Lounge
    • History of HM
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
    • The Flipside
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • From JHM
  • Industry Content
    • Patient Monitoring with Tech
An Official Publication of
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
    • Literature Lounge
    • History of HM
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
    • The Flipside
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • From JHM
  • Industry Content
    • Patient Monitoring with Tech

Oncology

  • Article

    Optimal Management of Febrile Neutropenia in Oncologic and Oncohematologic Patients

    April 6, 2026

    CLINICAL QUESTION: Is initial empiric antibiotic coverage important in patients with febrile neutropenia? How should the therapeutic strategy be defined? BACKGROUND: Febrile neutropenia is defined...

  • Article

    The Apparent Increase in the Incidence of Early-Onset Cancer in the U.S. Population

    April 6, 2026

    CLINICAL QUESTION: Does the observed rise in cancer rates reflect a true increase in incidence, or is it primarily attributable to heightened diagnostic scrutiny? BACKGROUND: In recent years, the...

  • Article

    Role of Ponsegromab in Treating Malignancy-Related Cachexia

    December 1, 2025

    CLINICAL QUESTION: Does treatment with ponsegromab, a monoclonal antibody inhibiting growth differentiation factor 15 (GDF-15), improve weight gain in patients with malignancy? BACKGROUND: Patients...

  • Article

    Extended Reduced-Dose Apixaban for Treatment of VTE in Cancer Patients

    December 1, 2025

    CLINICAL QUESTION: Following full-dose treatment for six months, is reduced-dose apixaban noninferior to full-dose apixaban for the prevention of further recurrence of venous thromboembolism (VTE) in...

  • Article

    iStopMM Risk Score Helps Predict Which MGUS Patients Need Bone Marrow Biopsy

    November 3, 2025

    CLINICAL QUESTION: Does my patient with a monoclonal protein and probable monoclonal gammopathy of undetermined significance (MGUS) need a bone marrow biopsy to rule out smoldering multiple myeloma...

  • Article

    Using AI/NLP to Improve Clinical Efficiency and Drive Patient-Centered Care in Cancer Research

    October 1, 2025

    CLINICAL QUESTION: Should clinicians use artificial intelligence with natural language processing (AI/NLP) to assess patient messages and review patient concerns to further develop meaningful, novel...

  • Article

    Structured Exercise After Adjuvant Chemotherapy for Colon Cancer

    July 31, 2025

    Clinical question: Does a three-year structured exercise program, started after adjuvant chemotherapy, improve disease-free and overall survival in patients with resected colon cancer compared to...

  • Article

    Reflections After Attending on an Oncology Hospitalist Service for Three Years

    June 24, 2025

    1. The Privilege of Immediate Impact Unlike many inpatient services, the oncology hospitalist role often means managing pivotal moments in a patient’s cancer journey. The admission might reflect a...

  • Article

    Understanding Potentially Preventable 7-Day Readmission Rates in Medical Oncology Patients

    January 1, 2025

    Clinical question: What are the rates and the underlying risk factors for seven-day, unplanned, potentially preventable re-admission (PPR), among solid tumor patients in a medical oncology...

  • Article

    Incidence of Colorectal Cancer in Patients Diagnosed with PLA

    November 1, 2024

    Dr. Katsnelson Clinical question: Is there an association between pyogenic liver abscess (PLA) and subsequent incidence of diagnosed colorectal cancer (CRC) and if so, should early screening for...

1 2 3 … 8Next
  • About The Hospitalist
  • Contact Us
  • The Editors
  • Editorial Board
  • Authors
  • Publishing Opportunities
  • Subscribe
  • Advertise
  • Copyright © 2026 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies.
    ISSN 1553-085X
  • Privacy Policy
  • Terms and Conditions
  • Cookie Preferences